(NKTR:Consolidated Issue Listed on NASDAQ Global Select )
Jerome Schentag Pharm D
Member of Strategic Advisory Board, Nektar Therapeutics
|Age||Total Calculated Compensation||This person is connected to 27 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Jerome Schentag, Pharm D serves as the Member of Strategic Advisory Board of Nektar Therapeutics. Mr. Schentag serves as Professor of Pharmaceutical Sciences and Pharmacy University of Buffalo School of Pharmacy His Area Of Expertise: Pharmacodynamic modeling specializing in Antibiotic dynamics.
455 Mission Bay Boulevard SouthPhone: 415-482-5300
San Francisco, California 94158
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Other Affiliations*There is no Company Affiliations data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Michael W. Aguiar||Chief Executive Officer, President and Director|
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|Peter S. Greenleaf||Chief Executive Officer and Director|
Sucampo Pharmaceuticals, Inc.
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee|
Emergent BioSolutions, Inc.
|$1.2M||Compensation as of Fiscal Year 2014.|